AU7547100A - Alkylpiperidi nylbenzo [d] isoxazole derivatives having psychotropic activity, pharmaceutical compositions containing the same, and a process for the preparation of the active ingredient - Google Patents

Alkylpiperidi nylbenzo [d] isoxazole derivatives having psychotropic activity, pharmaceutical compositions containing the same, and a process for the preparation of the active ingredient

Info

Publication number
AU7547100A
AU7547100A AU75471/00A AU7547100A AU7547100A AU 7547100 A AU7547100 A AU 7547100A AU 75471/00 A AU75471/00 A AU 75471/00A AU 7547100 A AU7547100 A AU 7547100A AU 7547100 A AU7547100 A AU 7547100A
Authority
AU
Australia
Prior art keywords
nylbenzo
alkylpiperidi
preparation
active ingredient
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU75471/00A
Inventor
Laszlo Balazs
Jozsef Barkoczy
Imre Doman
Istvan Gacsalyi
Zoltan Greff
Peter Kotay Nagy
Gyorgy Levay
Katalin Pallagi
Zoltan Ratkai
Eva Schmidt
Peter Seres
Gyula Simig
Gabor Szenasi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egis Pharmaceuticals PLC
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU9903043A external-priority patent/HUP9903043A2/en
Priority claimed from HU9903042A external-priority patent/HUP9903042A2/en
Application filed by Egyt Gyogyszervegyeszeti Gyar, Egis Pharmaceuticals PLC filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of AU7547100A publication Critical patent/AU7547100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
AU75471/00A 1999-09-09 2000-09-07 Alkylpiperidi nylbenzo [d] isoxazole derivatives having psychotropic activity, pharmaceutical compositions containing the same, and a process for the preparation of the active ingredient Abandoned AU7547100A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
HUP9903043 1999-09-09
HUP9903042 1999-09-09
HU9903043A HUP9903043A2 (en) 1999-09-09 1999-09-09 New benzo[d]isoxazole derivatives, process for their preparation and pharmaceutical compositions containing them
HU9903042A HUP9903042A2 (en) 1999-09-09 1999-09-09 Alkylpiperidine-benzo[d]isoxazole derivatives, process for their preparation and pharmaceutical compositions containing them
PCT/HU2000/000096 WO2001017993A1 (en) 1999-09-09 2000-09-07 Alkylpiperidi nylbenzo [d] isoxazole derivatives having psychotropic activity, pharmaceutical compositions containing the same, and a process for the preparation of the active ingredient

Publications (1)

Publication Number Publication Date
AU7547100A true AU7547100A (en) 2001-04-10

Family

ID=89999261

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75471/00A Abandoned AU7547100A (en) 1999-09-09 2000-09-07 Alkylpiperidi nylbenzo [d] isoxazole derivatives having psychotropic activity, pharmaceutical compositions containing the same, and a process for the preparation of the active ingredient

Country Status (2)

Country Link
AU (1) AU7547100A (en)
WO (1) WO2001017993A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007513197A (en) * 2003-12-08 2007-05-24 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー Heterocyclic substituted indane derivatives and related compounds for the treatment of schizophrenia
HUP0600555A3 (en) * 2006-07-03 2008-10-28 Egis Gyogyszergyar Nyrt Use of 4-chloro-5-{2-[4-(6-fluoro-1,2-benz[d]izoxazol-3-yl)piperidin-1-yl]ethylamino}2-methyl-3(2h)-piridazinon for the production of pharmaceutical compositions for influencing cognitive functions and causing neuroprotective effect
US8653069B2 (en) 2008-07-28 2014-02-18 Jiangsu Hengyi Pharmaceutical Co., Ltd. Aralkyl substituted piperidine or piperazine derivatives and their use for treating schizophrenia
CN102161658B (en) * 2011-03-01 2015-05-27 浙江华海药业股份有限公司 N-(naphthoxyalkyl)heteroarylpiperidine compounds and preparation method and applications thereof
CN102718758A (en) * 2011-03-31 2012-10-10 江苏恒谊药业有限公司 Quinolinone derivative and application thereof as anti-schizophrenic drug
JP5714152B2 (en) * 2014-03-26 2015-05-07 江蘇恒誼薬業有限公司 Aralkylpiperidine (or piperazine) derivatives and their use for the treatment of schizophrenia
WO2023144764A1 (en) 2022-01-29 2023-08-03 Suven Life Sciences Limited Benzoisothiazole and benzoisoxazole compounds for the treatment of mental disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
EP0402644B1 (en) * 1989-05-19 1995-08-16 Hoechst-Roussel Pharmaceuticals Incorporated N-(aryloxyalkyl)heteroarylpiperidines and -heteroarylpiperazines,a process for their preparation and their use as medicaments
DK60793D0 (en) * 1993-05-26 1993-05-26 Novo Nordisk As CHEMICAL COMPOUNDS, THEIR PREPARATION AND USE
IL117646A (en) * 1995-04-12 2000-06-01 Ferrer Int 7-¬3-¬4-(6-fluoro-1,2-benzisoxazole-3-YL)piperidin-1-YL¾propoxy¾3-alkyl-chromen-4-ones their preparation their uses and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
WO2001017993A1 (en) 2001-03-15

Similar Documents

Publication Publication Date Title
HK1067626A1 (en) Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient
HUP0203312A3 (en) Pharmaceutically active sulfonamide derivatives, process for their preparation, and pharmaceutical compositions and their use
AU3076700A (en) 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient
HUP0004383A3 (en) Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
AU4949800A (en) 2-arylpurine-9-acetamide derivatives, process for the preparation thereof, medicinal compositions containing the same and intermediates of the derivatives
HUP0201711A2 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
AU7962200A (en) Novel indole derivatives and drugs containing the same as the active ingredient
AU6404398A (en) New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
AU1307399A (en) Stabilized, dry pharmaceutical compositions for drug delivery and methods of preparing same
HUP0202934A3 (en) Arylsulfonamido-substituted hydroxamic acid derivatives, process for their preparation, pharmaceutical compositions containing them and use thereof
AU6309698A (en) Drugs containing aminopyridine derivatives as the active ingredient
AU5647199A (en) Carboxylic acid derivatives and drugs containing the same as the active ingredient
AU2001234107A1 (en) Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
AU1650401A (en) Oxadiazole derivatives and drugs containing these derivatives as the active ingredient
WO2000006606A3 (en) Erythromycin derivatives with antibiotic activity
AU7547100A (en) Alkylpiperidi nylbenzo [d] isoxazole derivatives having psychotropic activity, pharmaceutical compositions containing the same, and a process for the preparation of the active ingredient
AU3669700A (en) 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient
AU5443499A (en) Carboxylic acid derivatives and drugs containing the same as the active ingredient
PL345309A1 (en) Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
EP1059304A4 (en) Novel polysaccharide derivatives, process for the production thereof and medicinal compositions containing the same as the active ingredient
AU1556000A (en) Composition allowing predefined and controlled release of active ingredient, preparation thereof and use
HUP0201146A3 (en) Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin a, process for their preparation and pharmaceutical compositions containing them
AU6308900A (en) Isoquinoline derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the active substance
AU4845196A (en) 2-sulfinylnicotinamide derivatives, intermediate thereof, process for producing 2-sulfinylnicotinamide derivatives, and medicinal composition containing the same as active ingredient
HUP0203161A3 (en) Benzamidine derivatives, process for their preparation and pharmaceutical compositions containing them and their use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase